R. Scott Frayo
University of Washington
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by R. Scott Frayo.
Journal of the American Geriatrics Society | 2006
Michi Yukawa; David E. Cummings; Colleen C. Matthys; Holly S. Callahan; R. Scott Frayo; Charles Spiekerman; David S. Weigle
OBJECTIVES: To determine whether the failure of the orexigenic hormone ghrelin to increase as it normally does with weight loss contributes to impaired weight recovery in older persons.
American Journal of Physiology-gastrointestinal and Liver Physiology | 2014
Joost Overduin; Tracy Tylee; R. Scott Frayo; David E. Cummings
Plasma levels of the orexigenic hormone ghrelin are suppressed by meals with an efficacy dependent on their macronutrient composition. We hypothesized that heterogeneity in osmolarity among macronutrient classes contributes to these differences. In three studies, the impact of small intestinal hyperosmolarity was examined in Sprague-Dawley rats. In study 1, isotonic, 2.5×, and 5× hypertonic solutions of several agents with diverse absorption and metabolism properties were infused duodenally at a physiological rate (3 ml/10 min). Jugular vein blood was sampled before and at 30, 60, 90, 120, 180, 240, and 300 min after infusion. Plasma ghrelin was suppressed dose dependently and most strongly by glucose. Hyperosmolar infusions of lactulose, which transits the small intestine unabsorbed, and 3-O-methylglucose (3-O-MG), which is absorbed like glucose but remains unmetabolized, also suppressed ghrelin. Glucose, but not lactulose or 3-O-MG, infusions increased plasma insulin. In study 2, intestinal infusions of hyperosmolar NaCl suppressed ghrelin, a response that was not attenuated by coinfusion with the neural blocker lidocaine. In study 3, we reconfirmed that the low-osmolar lipid emulsion Intralipid suppresses ghrelin more weakly than isocaloric (but hypertonic) glucose. Importantly, raising Intralipids osmolarity to that of the glucose solution by nonabsorbable lactulose supplementation enhanced ghrelin suppression to that seen after glucose. Hyperosmolar ghrelin occurred particularly during the initial 3 postinfusion hours. We conclude that small intestinal hyperosmolarity 1) is sufficient to suppress ghrelin, 2) may combine with other postprandial mechanisms to suppress ghrelin, 3) might contribute to altered ghrelin regulation after gastric bypass surgery, and 4) may inform dietary modifications for metabolic health.
The New England Journal of Medicine | 2002
David E. Cummings; David S. Weigle; R. Scott Frayo; Patricia A. Breen; Marina K. Ma; E. Patchen Dellinger; Jonathan Q. Purnell
Nature Medicine | 2002
David E. Cummings; Karine Clément; Jonathan Q. Purnell; Christian Vaisse; Karen E. Foster; R. Scott Frayo; Michael W. Schwartz; Arnaud Basdevant; David S. Weigle
American Journal of Physiology-endocrinology and Metabolism | 2004
David E. Cummings; R. Scott Frayo; Corinne Marmonier; Roberte Aubert; Didier Chapelot
The Journal of Clinical Endocrinology and Metabolism | 2004
Tracey McLaughlin; Fahim Abbasi; Cindy Lamendola; R. Scott Frayo; David E. Cummings
Endocrinology | 2001
Brent E. Wisse; R. Scott Frayo; Michael W. Schwartz; David E. Cummings
The Journal of Clinical Endocrinology and Metabolism | 2003
David S. Weigle; David E. Cummings; Patricia D. Newby; Patricia A. Breen; R. Scott Frayo; Colleen C. Matthys; Holly S. Callahan; Jonathan Q. Purnell
Endocrinology | 2005
Joost Overduin; R. Scott Frayo; Harvey J. Grill; Joel M. Kaplan; David E. Cummings
The Journal of Clinical Endocrinology and Metabolism | 2005
Karen E. Foster-Schubert; Anne McTiernan; R. Scott Frayo; Robert S. Schwartz; Kumar B. Rajan; Yutaka Yasui; Shelley S. Tworoger; David E. Cummings